C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile
C. Michael Gibson MD

@cmichaelgibson

Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor clinicaltrialresults.org | RT ≠ endorse | Disclaimer: bit.ly/1mewZOF

ID: 879161563

linkhttp://www.linkedin.com/in/cmichaelgibson calendar_today14-10-2012 02:33:11

87,87K Tweet

433,433K Followers

365,365K Following

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

ADAPT-TAVR trial: in TAVR patients, edoxaban similar to DAPT in incidence of leaflet thrombosis on CT scans, no difference in rate of new cerebral thromboembolism. Download full slides from ADAPT-TAVR here: bit.ly/3DSDBxn #cardiology #tavr

ADAPT-TAVR trial: in TAVR patients, edoxaban similar to DAPT in incidence of leaflet thrombosis on CT scans, no difference in rate of new cerebral thromboembolism. Download full slides from ADAPT-TAVR here: bit.ly/3DSDBxn  #cardiology #tavr